ライフサイエンスコーパス: expander

1 s, dispersers, and a new class that we call "expanders".

2 ation (149 immediate implants and 116 tissue expanders).

3 ich the Cayley graph Cay(G; S) is an epsilon-expander.

4 dendritic cells were the most potent Vdelta2 expanders.

5 ss II(+) but not negative cells into Vdelta2 expanders.

6 this limitation by presenting neural etendue expanders.

7 te immune functions of CD8(+) T cells in non-expanders.

8 y breast procedures were most frequent after expander (2021/1000 discharges) and least frequent after

9 ion, patients were grouped into good or poor expanders across dose levels.

10 A Galilean beam expander addresses the signal vs local oscillator mismat

11 d expansion (expanders) or no expansion (non-expanders) after in vitro stimulation identified increas

12 sible by laser beam shaping using a 4:1 beam expander and a circular aperture for spatial mode filter

13 up to 5 weeks with anti-CD3/anti-CD28 T cell expander and high-dose interleukin-2 (IL-2).

14 Ninety-day complications were lowest after expander and highest after AT breast reconstruction (TE

15 hemodilutents: a non-oxygen-carrying plasma expander and two hemoglobin solutions with different oxy

16 r method at least matches quantum randomness expanders and classical world empirical extractors as me

17 No systemic toxicity was noted with the expanders and histology showed the material to be highly

18 tion was performed with a subpectoral tissue expander, and in 6 breasts, reconstruction was performed

19 ; malfunction of the filler port of a tissue expander; and wound dehiscence.

20 Self-expanding hydrogel tissue expanders appear to offer an intriguing reconstructive a

21 The expanders are placed in their dry, contracted states, an

22 ction-breast reconstruction with implants or expanders at the time of mastectomy-but there is a lack

23 compare short- and long-term outcomes after expander, autologous (AT), and direct-to-implant (DI) br

24 ctomy procedures with or without implant- or expander-based breast reconstruction.

25 econstruction and in those undergoing tissue expander breast reconstruction.

26 crews used for a tissue bone borne maxillary expander (C-expander) can fail if they contact tooth roo

27 rowth, but it has been suggested that slower expanders can take over under certain conditions.

28 or a tissue bone borne maxillary expander (C-expander) can fail if they contact tooth roots or perfor

29 nned revisions were highest among the tissue expander cohort (TE = 59.2% vs AT = 34.4% vs DI = 45.9%,

30 In this study, a shell-free tissue expander comprised only of a chemically cross-linked bio

31 nanoparticles, as a function of micelle pore expander concentration or stirring rate.

32 flap losses, and 1 patient underwent tissue expander explantation.

33 EXPANDER (EXPression ANalyzer and DisplayER) is a compre

34 After bonding open spring palatal expanders for 3-day, 5-day, 7-day, and retention for 28-

35 ts, dermis-fat grafts, or inflatable balloon expanders for orbital enlargement.

36 sent a new java-based graphical tool, called EXPANDER, for gene expression analysis and visualization

37 nking evolutionary dynamics to the theory of expander graphs.

38 hics were similar except more smokers in the expander group (7.7% vs 1.3%; P = 0.012).

39 gistic regression analysis, radiation to the expander had a higher risk of reconstruction failure tha

40 comparing reconstructive outcomes, radiated expanders had a higher failure rate (21.6% vs 11.4%; P =

41 EXPANDER has been continuously developed since 2003, hav

42 These expanders have an advantage of tissue expansion without

43 explored a novel, shapeable hydrogel tissue expander (HTE) in intraoral sites that had undergone pre

44 iotherapy on direct-to-implant versus tissue expander-implant reconstruction has not been examined.

45 he implant for women who opt for a two-stage expander-implant reconstruction.

46 nd reconstructive failure compared to tissue expander-implant reconstruction.

47 P = 0.034, respectively) when compared with expander/implants.

48 EXPANDER implements cutting-edge algorithms and makes th

49 Patients who received radiation with an expander in place had overall more complications (32.8%

50 roduction of human serum albumin as a plasma expander in the 1940s, considerable research has allowed

51 One expander in the BT group versus 5 in the control group r

52 ndicate that mechanical forces from a tissue expander induce broad molecular changes in gene expressi

53 r-particularly in terms of implanted orbital expanders-is the recent spate of long-term complications

54 le and controllable self-expansion, hydrogel expanders may offer yet another alternative or adjunctiv

55 ng miniscrews in a tissue bone borne palatal expander occurred due to certain risk factors, even when

56 PRACTICE ADVICE 8: IV albumin is the volume expander of choice in hospitalized patients with cirrhos

57 or older undergoing mastectomy and immediate expander or implant reconstruction for breast cancer (Ti

58 nt loss (defined as unplanned removal of the expander or implant), infection requiring treatment with

59 omplications were in patients with immediate expander or implant-based reconstruction.

60 atment should be directed towards the tissue expander or the implant for women who opt for a two-stag

61 D8(+) T cells from donors who had expansion (expanders) or no expansion (non-expanders) after in vitr

62 l patients undergoing mastectomy with tissue expander placement during a 2-year period.

63 of botulinum toxin for mastectomy and tissue expander placement significantly reduced postoperative p

64 frequent reconstruction technique was tissue expander placement.

65 dicled flap reconstruction, and 2 had tissue expander placement.

66 le-sparing mastectomies (SPrNSM) with tissue expander reconstruction from February 1, 2020, through J

67 95% CI, 0.51-0.73) and the immediate tissue expander reconstruction subgroup (OR, 0.49; 95% CI, 0.30

68 and postoperative pain, facilitating tissue expander reconstruction.

69 ts had chest wall reconstructions; three had expanders removed for infection before radiation therapy

70 Conventional tissue expanders require a silicone shell inflated either by ex

71 0.09 to 0.04]), hypotension requiring volume expanders (RR, 0.71 [95% CI, 0.41 to 1.25]; RD, -0.09 [9

72 anchoring miniscrews on 70 patients whose C-expanders showed sufficient stability after palatal expa

73 ize (2 +/- 2 cm versus 2 +/- 3 cm; P = 0.4), expander size and volume (429 +/- 119 mL versus 510 +/-

74 We defined expander states as those who expanded Medicaid on or bef

75 Between 2013 and 2018, >75% of the expander states had increases in prescription rates of b

76 OR, 0.57; 95% CI, 0.37-0.88), and the tissue expander subgroup (OR, 0.41; 95% CI, 0.23-0.72).

77 4 women who underwent mastectomy with tissue expander (TE: 70.5%), autologous (AT: 18.1%), or direct

78 oup analyses versus each of the other volume expanders tested (e.g., dextran, gelatin, hydroxyethyl s

79 tic gradient scaling, that model requires an expander that spreads with minimal loss throughout a mor

80 After 3 hrs, an infusion of the PV expander under study was started at a volume of 12mL/kg

81 lution of succinylated gelatin (SG, a plasma expander used for nephroprotection) in a random crossove

82 miniscrews for a tissue-bone-borne palatal C-expander using a finite element method.

83 ta cardiovascular drug prescription rates in expander versus nonexpander states.

84 With neural etendue expanders, we experimentally achieve 64 x etendue expans

85 of the current macromolecular plasma volume expanders, we found that it filtered readily into lymph,

86 The new type of hydrogel expanders were characterized in vitro as well as in vivo

87 Hydrogel tissue expanders were recently adapted for use in congenital an

88 on the granule cell layer as a combinatorial expander, where each granule cell represents a unique co

89 Since their invention, tissue expanders, which are designed to trigger additional skin

90 d several mechanisms that could provide slow expanders with a local competitive advantage and showed